Nurix Therapeutics(NRIX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRIX Nurix Therapeutics

休市中 12-20 16:00:00 EST

19.83

-0.21

-1.05%

盘后19.83

+0.000.00%

16:32 EST

最高20.61	最低19.66	成交量291.38万
今开19.90	昨收20.04	日振幅4.74%
总市值14.05亿	流通市值11.45亿	总股本7,084万
成交额5,795万	换手率5.05%	流通股本5,774万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRIX","market":"US","secType":"STK","nameCN":"Nurix Therapeutics","latestPrice":19.83,"timestamp":1734728400000,"preClose":20.04,"halted":0,"volume":2913822,"hourTrading":{"tag":"盘后","latestPrice":19.83,"preClose":19.83,"latestTime":"16:32 EST","volume":434539,"amount":8616894.604,"timestamp":1734730379010},"delay":0,"floatShares":57744816,"shares":70836282,"eps":-2.891508,"marketStatus":"休市中","marketStatusCode":7,"change":-0.21,"latestTime":"12-20 16:00:00 EST","open":19.9,"high":20.61,"low":19.66,"amount":57954739.48209,"amplitude":0.047405,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.891508,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1595563200000,"adjPreClose":20.04,"preHourTrading":{"tag":"盘前","latestPrice":20.07,"preClose":20.04,"latestTime":"09:28 EST","volume":111,"amount":2229.619926,"timestamp":1734704927114},"postHourTrading":{"tag":"盘后","latestPrice":19.83,"preClose":19.83,"latestTime":"16:32 EST","volume":434539,"amount":8616894.604,"timestamp":1734730379010},"volumeRatio":3.3359741700237406,"impliedVol":0.8208,"impliedVolPercentile":0.4643},"requestUrl":"/m/hq/s/NRIX","defaultTab":"news","newsList":[{"id":"2492815636","title":"Nurix Therapeutics, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492815636","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492815636?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:28","pubTimestamp":1734553700,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时28分，Nurix Therapeutics, Inc.股票出现波动，股价大幅跳水5.00%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.38%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042820ab829ac4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042820ab829ac4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRIX","BK4139"],"gpt_icon":0},{"id":"2492612852","title":"Nurix Therapeutics, Inc.盘中异动 快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492612852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492612852?lang=zh_cn&edition=full","pubTime":"2024-12-17 01:10","pubTimestamp":1734369004,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日01时10分，Nurix Therapeutics, Inc.股票出现异动，股价大幅拉升5.08%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217011004984c73cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217011004984c73cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","LENZ","BK4139"],"gpt_icon":0},{"id":"2491356640","title":"Nurix Therapeutics, Inc.盘中异动 大幅跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491356640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491356640?lang=zh_cn&edition=full","pubTime":"2024-12-13 03:39","pubTimestamp":1734032373,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日03时39分，Nurix Therapeutics, Inc.股票出现波动，股价急速跳水5.07%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.23%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121303393395e94145&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121303393395e94145&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","LENZ","BK4139"],"gpt_icon":0},{"id":"2490191120","title":"Nurix Therapeutics, Inc.盘中异动 快速拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490191120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490191120?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:31","pubTimestamp":1733841082,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时31分，Nurix Therapeutics, Inc.股票出现异动，股价快速上涨5.18%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223123a1e397ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223123a1e397ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRIX"],"gpt_icon":0},{"id":"2490748437","title":"Nurix Therapeutics, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490748437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490748437?lang=zh_cn&edition=full","pubTime":"2024-12-09 23:48","pubTimestamp":1733759306,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日23时48分，Nurix Therapeutics, Inc.股票出现波动，股价快速跳水5.01%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209234826a1e0d14b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209234826a1e0d14b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRIX"],"gpt_icon":0},{"id":"2489239129","title":"Nurix Therapeutics, Inc.盘中异动 早盘急速上涨5.58%报21.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489239129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489239129?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:38","pubTimestamp":1733495899,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时38分，Nurix Therapeutics, Inc.股票出现波动，股价大幅上涨5.58%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223819971c2510&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223819971c2510&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRIX"],"gpt_icon":0},{"id":"2484744971","title":"Nurix Therapeutics, Inc.盘中异动 下午盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484744971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484744971?lang=zh_cn&edition=full","pubTime":"2024-11-20 03:02","pubTimestamp":1732042921,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日03时02分，Nurix Therapeutics, Inc.股票出现异动，股价大幅拉升5.09%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120030201971a780b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120030201971a780b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRIX"],"gpt_icon":0},{"id":"2484671500","title":"Nurix Therapeutics, Inc.盘中异动 早盘股价大跌5.13%报21.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484671500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484671500?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:56","pubTimestamp":1731941796,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时56分，Nurix Therapeutics, Inc.股票出现波动，股价大幅下跌5.13%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822563798e43459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822563798e43459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRIX","LENZ"],"gpt_icon":0},{"id":"2483370749","title":"Nurix Therapeutics, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483370749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483370749?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:52","pubTimestamp":1731682320,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时52分，Nurix Therapeutics, Inc.股票出现异动，股价急速跳水5.01%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.02%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115225201abc4f233&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115225201abc4f233&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRIX","LENZ"],"gpt_icon":0},{"id":"2483392450","title":"Nurix Therapeutics, Inc.盘中异动 大幅跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483392450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483392450?lang=zh_cn&edition=full","pubTime":"2024-11-13 01:13","pubTimestamp":1731431626,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日01时13分，Nurix Therapeutics, Inc.股票出现异动，股价急速跳水5.12%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113011346971a6160&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113011346971a6160&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRIX"],"gpt_icon":0},{"id":"2482738446","title":"Nurix Therapeutics, Inc.盘中异动 股价大涨5.82%报28.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738446?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:36","pubTimestamp":1731335818,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时36分，Nurix Therapeutics, Inc.股票出现波动，股价大幅上涨5.82%。截至发稿，该股报28.93美元/股，成交量3.6102万股，换手率0.05%，振幅4.13%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223658abb664e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223658abb664e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","BK4139","LENZ"],"gpt_icon":0},{"id":"2481331138","title":"Nurix Therapeutics, Inc.盘中异动 早盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481331138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481331138?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:49","pubTimestamp":1730994551,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时49分，Nurix Therapeutics, Inc.股票出现异动，股价快速拉升5.13%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107234911a22114de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107234911a22114de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRIX"],"gpt_icon":0},{"id":"2481985918","title":"Nurix Therapeutics, Inc.盘中异动 早盘急速拉升6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481985918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481985918?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903489,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Nurix Therapeutics, Inc.股票出现波动，股价快速拉升6.06%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622312998e40d75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622312998e40d75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRIX","LENZ"],"gpt_icon":0},{"id":"2479928245","title":"Nurix Therapeutics, Inc.盘中异动 早盘大幅跳水5.03%报25.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479928245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479928245?lang=zh_cn&edition=full","pubTime":"2024-10-29 22:47","pubTimestamp":1730213240,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日22时47分，Nurix Therapeutics, Inc.股票出现异动，股价快速下挫5.03%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029224720a1f5d9b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029224720a1f5d9b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","LENZ","BK4139"],"gpt_icon":0},{"id":"2478937236","title":"Nurix Therapeutics, Inc.盘中异动 股价大涨5.08%报26.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478937236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478937236?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:15","pubTimestamp":1729869308,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时15分，Nurix Therapeutics, Inc.股票出现波动，股价急速上涨5.08%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025231509a1eac26e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025231509a1eac26e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRIX"],"gpt_icon":0},{"id":"1190672997","title":"异动解读 | Nurix Therapeutics股价大涨5.21% 市场关注公司新药研发进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1190672997","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190672997?lang=zh_cn&edition=full","pubTime":"2024-10-14 22:26","pubTimestamp":1728915979,"startTime":"0","endTime":"0","summary":"2024年10月14日,Nurix Therapeutics股价盘中大涨5.21%,引发市场关注。尽管没有直接相关的新闻解释股价大涨的原因,但从公司业务动态和最新财报数据来看,市场可能对其新药研发进展抱有期待。Nurix Therapeutics是一家从事生物技术和药物开发的公司,其主要产品线包括用于治疗B细胞恶性肿瘤的BTK靶向蛋白降解药物NX-2127,以及用于免疫肿瘤学适应症的口服CBL-B抑制剂NX-1607等。另外,Nurix Therapeutics最新的财报显示公司目前仍处于亏损状态,但营业收入有所增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NRIX"],"gpt_icon":0},{"id":"2475168398","title":"Nurix Therapeutics, Inc.盘中异动 早盘股价大涨5.21%报24.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475168398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475168398?lang=zh_cn&edition=full","pubTime":"2024-10-14 22:15","pubTimestamp":1728915335,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日22时15分，Nurix Therapeutics, Inc.股票出现波动，股价快速拉升5.21%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014221535971a01fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014221535971a01fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","BK4139","LENZ"],"gpt_icon":0},{"id":"2474094404","title":"Nurix Therapeutics, Inc.盘中异动 股价大涨7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474094404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474094404?lang=zh_cn&edition=full","pubTime":"2024-10-11 21:33","pubTimestamp":1728653588,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日21时33分，Nurix Therapeutics, Inc.股票出现异动，股价急速拉升7.98%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101121330895a07513&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101121330895a07513&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRIX"],"gpt_icon":0},{"id":"2474066421","title":"BUZZ-杰富瑞将 Nurix Therapeutics 评为 \"买入\"，并设定最高市盈率","url":"https://stock-news.laohu8.com/highlight/detail?id=2474066421","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474066421?lang=zh_cn&edition=full","pubTime":"2024-10-11 18:12","pubTimestamp":1728641530,"startTime":"0","endTime":"0","summary":"    10月11日 - ** 杰富瑞对药物开发商Nurix Therapeutics   的评级为 \"买入\"，目标价为41美元，这是华尔街的最高价。** 杰富瑞的 \"买入 \"评级是该股自7月以来的首个看涨评级--LSEG** 券商的PT较该股上次收盘价上涨约88%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRIX","BK4127","BK4139","LENZ","JEF"],"gpt_icon":0},{"id":"2473473305","title":"Nurix Therapeutics, Inc.盘中异动 早盘股价大涨5.11%报22.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473473305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473473305?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:50","pubTimestamp":1728395411,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日21时50分，Nurix Therapeutics, Inc.股票出现波动，股价快速拉升5.11%。截至发稿，该股报22.64美元/股，成交量3.8818万股，换手率0.06%，振幅5.85%。Nurix Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Nurix Therapeutics, Inc.公司简介：Nurix Therapeutics Inc是一家生物制药公司，专注于口服，小分子疗法的发现，开发和商业化，这些疗法旨在调节细胞蛋白水平，作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100821501198e3b2e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100821501198e3b2e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nurixtx.com","stockEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.1241},{"period":"3month","weight":-0.226},{"period":"6month","weight":-0.069},{"period":"1year","weight":1.1554},{"period":"ytd","weight":0.9215}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nurix Therapeutics, Inc.于2009年8月27日在特拉华州成立。该公司是一家生物制药公司，专注于发现、开发和商业化口服小分子疗法，旨在调节细胞蛋白水平，作为癌症和免疫紊乱的新治疗方法。利用他们在E3连接酶方面的广泛专业知识以及他们的专有DNA编码库，该公司已经建立了一个集成的发现平台DELigase，以识别和开发针对E3连接酶的新药物候选。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.09139},{"month":2,"riseRate":0.25,"avgChangeRate":0.044459},{"month":3,"riseRate":0.25,"avgChangeRate":-0.032138},{"month":4,"riseRate":0.5,"avgChangeRate":-0.046933},{"month":5,"riseRate":0.5,"avgChangeRate":0.018484},{"month":6,"riseRate":0.5,"avgChangeRate":0.129707},{"month":7,"riseRate":0.75,"avgChangeRate":0.109681},{"month":8,"riseRate":0.6,"avgChangeRate":0.053338},{"month":9,"riseRate":0.2,"avgChangeRate":0.013466},{"month":10,"riseRate":0.4,"avgChangeRate":-0.0754},{"month":11,"riseRate":0.4,"avgChangeRate":0.106468},{"month":12,"riseRate":0.4,"avgChangeRate":0.043644}],"exchange":"NASDAQ","name":"Nurix Therapeutics","nameEN":"Nurix Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nurix Therapeutics(NRIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nurix Therapeutics(NRIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nurix Therapeutics,NRIX,Nurix Therapeutics股票,Nurix Therapeutics股票老虎,Nurix Therapeutics股票老虎国际,Nurix Therapeutics行情,Nurix Therapeutics股票行情,Nurix Therapeutics股价,Nurix Therapeutics股市,Nurix Therapeutics股票价格,Nurix Therapeutics股票交易,Nurix Therapeutics股票购买,Nurix Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nurix Therapeutics(NRIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nurix Therapeutics(NRIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}